Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.santini@uniroma1.it
Daniele Santini
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
daniele.santini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective analysis of progression-free (PFS) and overall survival (OS) in the “Real Life”
ANNALS OF ONCOLOGY
2015
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety
EUROPEAN JOURNAL OF CANCER
2015
Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment: results of an Italian multicentre study
EUROPEAN UROLOGY
2015
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2015
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions
BLOOD
2015
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs)
ANNALS OF ONCOLOGY
2015
Targeted therapies for bone metastases
Targeted Therapies for Solid Tumors
2015
Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients
ANNALS OF ONCOLOGY
2015
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus)
ANNALS OF ONCOLOGY
2015
Targeted therapies for bone metastases
Targeted Therapies for Solid Tumors
2015
Interventional radiologist's perspective on the management of bone metastatic disease
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2015
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence
BREAST CANCER RESEARCH
2015
Emerging kinase inhibitors of the treatment of gastric cancer
EXPERT OPINION ON EMERGING DRUGS
2015
Deregulation of dicer and mir-155 expression in liposarcoma
ONCOTARGET
2015
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
SEMINARS IN CANCER BIOLOGY
2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
TARGETED ONCOLOGY
2015
Percutaneous long bone cementoplasty for palliation of malignant lesions of the limbs: a systematic review
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
2015
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter
CURRENT ONCOLOGY
2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
PLOS ONE
2015
« prima
< precedente
…
7
8
9
10
11
12
13
14
15
16
17
18
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma